THE TMEM106B LOCUS AND TDP-43 PATHOLOGY IN OLDER PERSONS WITHOUT FTLD Response

被引:0
|
作者
Schneider, Julie A.
Yu, Lei
Bennett, David A.
机构
关键词
HIPPOCAMPAL SCLEROSIS; DISEASE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1355 / 1355
页数:1
相关论文
共 50 条
  • [21] TMEM106B p.T185S as the potential protective factor in FTLD-TDP
    Nicholson, A. M.
    Finch, N. A.
    Wojtas, A.
    Baker, M.
    Castanedes-Casey, M.
    Rousseau, L.
    Dickson, D. W.
    Rademakers, R.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 67 - 68
  • [22] Tau negative FTLD without abnormal TDP-43 immunoreactivity
    Josephs, Keith A.
    Stroh, Alex
    Dickson, Dennis W.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (05): : 513 - 513
  • [23] Tau Negative FTLD Without Abnormal TDP-43 Immunoreactivity
    Josephs, Keith A.
    Stroh, Alex
    Dickson, Dennis W.
    FASEB JOURNAL, 2008, 22
  • [24] Association of TDP-43 Pathology With Domain-specific Literacy in Older Persons
    Kapasi, Alifiya
    Yu, Lei
    Stewart, Christopher C.
    Schneider, Julie A.
    Bennett, David A.
    Boyle, Patricia A.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2019, 33 (04): : 315 - 320
  • [25] Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD
    Yamashita, Takenari
    Teramoto, Sayaka
    Kwak, Shin
    NEUROSCIENCE RESEARCH, 2016, 107 : 63 - 69
  • [26] The FTLD risk factor TMEM106B is linked to neuronal cell death
    Suzuki, Hiroaki
    Matsuoka, Masaaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S116 - S116
  • [27] Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes
    Yasushi Nishihira
    Tamar Gefen
    Qinwen Mao
    Christina Appin
    Missia Kohler
    Jamie Walker
    Rosa Rademakers
    Alfred Rademaker
    Emily Rogalski
    Sandra Weintraub
    Changiz Geula
    M-Marsel Mesulam
    Eileen H. Bigio
    Acta Neuropathologica, 2019, 138 : 167 - 169
  • [28] Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes
    Nishihira, Yasushi
    Gefen, Tamar
    Mao, Qinwen
    Appin, Christina
    Kohler, Missia
    Walker, Jamie
    Rademakers, Rosa
    Rademaker, Alfred
    Rogalski, Emily
    Weintraub, Sandra
    Geula, Changiz
    Mesulam, M-Marsel
    Bigio, Eileen H.
    ACTA NEUROPATHOLOGICA, 2019, 138 (01) : 167 - 169
  • [29] Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes
    Pellerino, Alessia
    Lomartire, A.
    Naldi, A.
    Buccinna, B.
    Maffeo, E.
    Ramondetti, C.
    Lupino, E.
    Rinaudo, M. T.
    Piccinini, M.
    Rainero, I
    De Marco, G.
    Giordana, M. T.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 99 - 100
  • [30] TDP-43, Dementia and Cognitive Function in Older Persons
    Schneider, Julie A.
    Leurgans, Sue E.
    Kriho, Virginia
    Trojanowski, John Q.
    Bennett, David A.
    NEUROLOGY, 2011, 76 (09) : A641 - A641